Organto Foods (OGO) Q4 2023 earnings summary

Executive summary

• Fiscal 2023 sales reached $27.7 million, up 25% year-over-year, marking the highest annual sales in company history.

• Gross profit increased 94% to $2.5 million, or 8.9% of sales, also a record high for the company.

• Despite growth, profitability targets were not met, prompting a major restructuring, including streamlining the product portfolio, refocusing marketing, reducing costs, and selling three subsidiaries.

• Restructuring of convertible debenture obligations is underway to reduce debt and improve operating flexibility.

Financial highlights

• Adjusted gross profit, accounting for currency hedging, was 8.1% of sales versus 7.1% in the prior year.

• Cash overhead costs fell to 28.5% of sales from 32.9% year-over-year, with reductions in the latter half of 2023.

• Operating loss (including stock-based compensation) improved to $6.1 million from $6.9 million year-over-year.

• Net interest and accretion expenses rose to $3.9 million, driven by a one-time $1.9 million debenture accretion charge.

• Net loss increased to $13.4 million from $10.8 million, due to higher impairment charges, increased debenture costs, and losses on derivatives.

Outlook and guidance

• Management expects restructuring efforts to yield improved results in future periods.

• Plans to file Q1 and Q2 2024 financials soon, aiming to lift the current Cease Trade Order.